Join the club for FREE to access the whole archive and other member benefits.

Luis Martinez

President at XanoGene Clinic and Co-Founder at Clinical Peptide Society.

Dr. Luis Martínez is a Regenerative Medicine, Anti-aging and Cell Therapy specialist, clinical researcher and biomedical consultant. He earned his medical degree at The Ponce School of Medicine and completed his residency training at the prestigious University of Pennsylvania. He also completed an Advanced Training Course in Stem Cells in Cancer at the Ponce Health Sciences University/ Magee Research Institute consortium. He is board certified in Clinical Lipidology. Dr. Martinez holds a Master of Public Health with a concentration in Epidemiology and is fellowship trained in Biosecurity. He is the president of Xanogene Clinic, which specialized in Regenerative and Age Management Medicine. He also founded and presides over Regenera Global, a multinational corporation specializing in biotech product development, research, and clinical consulting.

Dr. Martinez is also Co-Founder of the Clinical Peptide Society, a US based professional organization aimed at educating physicians and advancing the use of peptide therapeutics. Alongside with the Age Management Medicine Group, he and his colleague have developed the world’s first Peptide Certification Program and have so far trained and educated over 400 physicians. He additionally trains physicians in other aspects of Regenerative and Age Management Medicine through his physician training portal Elite Group MD.

Visit website: https://www.xanogenepr.net/directorio-meacutedico.html

 luis-martinez-61ab7910

See also: Health Organisation XanoGene Clinic - Anti-aging, health and wellness center.

Details last updated 01-May-2021

Luis Martinez is also referenced in the following:

Senolytic Therapy Network (STN)

Company developing the world’s first Certified Senotherapeutics Practictioner program.

Luis Martinez News

Raising awareness on senolytic drugs as a promising anti-ageing medicine

Raising awareness on senolytic drugs as a promising anti-ageing medicine

Longevity Technology - 30-Apr-2021

Senolytic Therapy Network aims to take the senotherapeutics from lab to clinic